# OnCo record nct07288879 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07288879/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07288879", "NCT07288879" ;
  schema:name "DALY II Japan/MB-CART2019.1 for DLBCL"@en ;
  schema:alternateName "DALY II Japan"@en ;
  schema:description "A phase 2 trial of Zamtocabtagene autoleucel in diffuse large b-cell lymphoma, run by Miltenyi Biomedicine GmbH, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07288879/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07288879> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-12-11" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/zamtocabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/miltenyi-biomedicine/> .